PT  - JOURNAL ARTICLE
AU  - Wallace, David J
AU  - Ackland, Graeme J
TI  - Abrupt increase in the UK coronavirus death-case ratio in December 2020
AID  - 10.1101/2021.01.21.21250264
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.21.21250264
4099  - http://medrxiv.org/content/early/2021/01/22/2021.01.21.21250264.short
4100  - http://medrxiv.org/content/early/2021/01/22/2021.01.21.21250264.full
AB  - Objective to determine the statistical relationship between reported deaths and infections in the UK coronavirus outbreakDesign Publicly available UK government data is used to determine a relationship between reported cases and deaths, taking into account various UK regions, age profiles and prevalence of the variant of concern (VOC) B.1.1.7.Main Outcome Measures Establishing a simple statistical relationship between detected cases and subsequent mortality.Results Throughout October and November 2020, deaths in England are well described as 1/55th of detected cases from 12 days previously. After that, the relationship no longer holds and deaths are significantly higher. This is especially true in regions affected by the VOC B.1.1.7Conclusions In early December, some new factor emerged to increase the case-fatality rate in the UK.What is already known on this topic The infection-mortality ratio enables one to predict future deaths based on current infections. Incomplete monitoring of infection may be sufficient to predict future trends.What the study adds For the specific case of the second wave of coronavirus infection in the UK, we show a clear mathematical relationship between detected infections (positive tests) and subsequent deaths. This relationship begins to fail in December, with unexpectedly high death rates. This may be correlated in time and region with the emergence of the Variant of Concern B 1.1.7.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge support from UKRI grant ST/V00221X/1 under COVID-19 initiative. This work was undertaken [in part] as a contribution to the Rapid Assistance in Modelling the Pandemic (RAMP) initiative, coordinated by the Royal Society.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of EdinburghAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is publicly available via references provided in the paper